Patents by Inventor Jon CHU

Jon CHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Power monitoring and distributing systems
    Patent number: 11694841
    Abstract: A current transformer having a body having an upper half and a lower half hingedly connected to the upper half, a pair of ferrite cores located within one of the upper half and the lower half of the body, the pair of ferrite cores defining a gap formed between each ferrite core of the pair of ferrite cores, and a sensor located within the gap formed between each ferrite core of the pair of ferrite cores.
    Type: Grant
    Filed: August 9, 2018
    Date of Patent: July 4, 2023
    Assignee: Verdigris Technologies, Inc.
    Inventors: Thomas Chung, Jon Chu, Santo Ko, Danny Serven, Martin Chang, Jared Kruzek, Diego Torres, Sami Shad, Joe Phaneuf, Jacques Kvam, Anjali Sehrawat, Daniela Li, Michael Roberts, Jason Goldman
  • POWER MONITORING AND DISTRIBUTING SYSTEMS
    Publication number: 20210142941
    Abstract: A current transformer having a body having an upper half and a lower half hingedly connected to the upper half, a pair of ferrite cores located within one of the upper half and the lower half of the body, the pair of ferrite cores defining a gap formed between each ferrite core of the pair of ferrite cores, and a sensor located within the gap formed between each ferrite core of the pair of ferrite cores.
    Type: Application
    Filed: August 9, 2018
    Publication date: May 13, 2021
    Inventors: Thomas CHUNG, Jon CHU, Santo KO, Danny SERVEN, Martin CHANG, Jared KRUZEK, Diego TORRES, Sami SHAD, Joe PHANEUF, Jacques KVAM, Anjali SEHRAWAT, Daniela LI, Michael ROBERTS, Jason GOLDMAN
  • Parenteral compositions of celecoxib
    Patent number: 9968621
    Abstract: Parenteral (injectable) celecoxib emulsions and nanoemulsions are disclosed as are their use to treat pain in patients so afflicted. The emulsions are generally oil in water emulsions often comprised of an oil phase including an oil and a lecithin wherein the mean droplet size of the discontinuous oil phase is about 200 nanometers or less.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: May 15, 2018
    Assignee: Dr. Reddy's Laboratories Ltd.
    Inventors: Franklin Okumu, Jan-Jon Chu, Julie Ann Webb, Rafael Anthony Sabino, Andrew Xian Chen
  • PARENTAL COMPOSITIONS OF CELECOXIB
    Publication number: 20160354390
    Abstract: Parenteral (injectable) celecoxib emulsions and nanoemulsions are disclosed as are their use to treat pain in patients so afflicted. The emulsions are generally oil in water emulsions often comprised of an oil phase including an oil and a lecithin wherein the mean droplet size of the discontinuous oil phase is about 200 nanometers or less.
    Type: Application
    Filed: August 18, 2016
    Publication date: December 8, 2016
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Franklin Okumu, Jan-Jon Chu, Julie Ann Webb, Rafael Anthony Sabino, Andrew Xian Chen
  • Parenteral compositions of celecoxib
    Patent number: 9446056
    Abstract: Parenteral (injectable) celecoxib emulsions and nanoemulsions are disclosed as are their use to treat pain in patients so afflicted. The emulsions are generally oil in water emulsions often comprised of an oil phase including an oil and a lecithin wherein the mean droplet size of the discontinuous oil phase is about 200 nanometers or less.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: September 20, 2016
    Assignee: Dr. Reddy's Laboratories Ltd.
    Inventors: Franklin Okumu, Jan-Jon Chu, Julie Ann Webb, Rafael Anthony Sabino, Andrew Xian Chen
  • PARENTERAL COMPOSITIONS OF CELECOXIB
    Publication number: 20150224121
    Abstract: Parenteral (injectable) celecoxib emulsions and nanoemulsions are disclosed as are their use to treat pain in patients so afflicted. The emulsions are generally oil in water emulsions often comprised of an oil phase including an oil and a lecithin wherein the mean droplet size of the discontinuous oil phase is about 200 nanometers or less.
    Type: Application
    Filed: February 11, 2015
    Publication date: August 13, 2015
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Franklin Okumu, Jan-Jon Chu, Julie Ann Webb, Rafael Anthony Sabino, Andrew Xian Chen
  • Lyophilized formulations of Salinosporamide A
    Patent number: 7824698
    Abstract: Lyophilized formulations comprising Salinosporamide A or analogs thereof are provided. In some aspects, lyophilized formulations comprising Salinosporamide A or analogs thereof and bulking agents are provided. Also provided are methods of lyophilizing Salinosporamide A or analogs thereof. In some aspects, a solvent or co-solvent system is utilized. Also provided are methods of administering Salinosporamide A or analogs thereof to patients.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: November 2, 2010
    Assignee: Nereus Pharmaceuticals, Inc.
    Inventors: Barbara Potts, Ramsharan Singh, Jan-Jon Chu, Bao Viet Mai, Natasha Reddinger, Cheryl (Billstrom) Sifferlen
  • LYOPHILIZED FORMULATIONS OF SALINOSPORAMIDE A
    Publication number: 20080188544
    Abstract: Lyophilized formulations comprising Salinosporamide A or analogs thereof are provided. In some aspects, lyophilized formulations comprising Salinosporamide A or analogs thereof and bulking agents are provided. Also provided are methods of lyophilizing Salinosporamide A or analogs thereof. In some aspects, a solvent or co-solvent system is utilized. Also provided are methods of administering Salinosporamide A or analogs thereof to patients.
    Type: Application
    Filed: February 4, 2008
    Publication date: August 7, 2008
    Applicant: NEREUS PHARMACEUTICALS, INC.
    Inventors: Barbara Potts, Ramsharan Singh, Jan-Jon Chu, Bao Viet Mai, Natasha Reddinger, Cheryl Sifferlen
  • Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-one
    Patent number: 7268126
    Abstract: The present invention relates to novel polymorphic and amorphous forms of a phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: September 11, 2007
    Assignees: Agouron Pharmaceuticals, Inc., Cancer Research Technology Ltd.
    Inventors: Jia Liu, Naresh Nayyar, Ming Guo, Zhen-Ping Wu, Bennett Chaplin Borer, Aparna Nadig Srirangam, Mark Bryan Mitchell, Yi Li, Jan-Jon Chu
  • Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-ce]indol-6-one
    Publication number: 20060100198
    Abstract: The present invention relates to novel polymorphic and amorphous forms of a phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one, and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
    Type: Application
    Filed: September 21, 2005
    Publication date: May 11, 2006
    Inventors: Jia Liu, Naresh Nayyar, Ming Guo, Zhen-Ping Wu, Bennett Borer, Aparna Srirangam, Mark Mitchell, Yi Li, Jan-Jon Chu
  • Salts of tricyclic inhibitors of poly(ADP-ribose) polymerases
    Publication number: 20040248879
    Abstract: Pharmaceutically acceptable salts of compounds of the formula below are poly(ADP-ribosyl)transferase (PARP) inhibitors, and are useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease. As cancer therapeutics, the compounds of the invention may be used, e.g., in combination with cytotoxic agents and/or radiation.
    Type: Application
    Filed: March 29, 2004
    Publication date: December 9, 2004
    Applicant: Agouron Pharmaceuticals, Inc.
    Inventors: Stacie Canan-Koch, Jan-Jon Chu, Jia Liu, Jean Matthews